Company intelligence / Profile preview

The DNA Company

Toronto, Ontario, Canadathednacompany.com ↗

Ownership: Private
Development stage: Commercial

Overview

The company offers evidence-based therapies and recommendations by analyzing individual genomic data to inform lifestyle changes, chronic disease prevention strategies, and risk mitigation. It has developed AI-driven digital therapeutics platforms that integrate functional genomics with self-management tools. There are no published results from interventional clinical trials as would be typical in pharma/biotech.

Therapeutic areas: Metabolic DisordersImmunology
Modalities: Non-pharmacological therapy (personalized health strategies based on genomics)
Industry: Molecular Diagnostics

Partnerships

IBM partnership via My Pain Sensei/Green Sky Labs for AI-driven medical record analysis prior to acquisition.

Beyond the preview

Go deeper on The DNA Company.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on The DNA Company.

Explore the full profile